Schnieders Capital Management LLC Reduces Position in UnitedHealth Group Incorporated (NYSE:UNH)

Schnieders Capital Management LLC decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 16,931 shares of the healthcare conglomerate’s stock after selling 962 shares during the quarter. UnitedHealth Group makes up about 2.0% of Schnieders Capital Management LLC’s portfolio, making the stock its 12th biggest holding. Schnieders Capital Management LLC’s holdings in UnitedHealth Group were worth $8,914,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Kraft Davis & Associates LLC lifted its position in UnitedHealth Group by 3.4% in the third quarter. Kraft Davis & Associates LLC now owns 577 shares of the healthcare conglomerate’s stock valued at $294,000 after buying an additional 19 shares during the last quarter. Iron Horse Wealth Management LLC lifted its position in shares of UnitedHealth Group by 1.6% during the third quarter. Iron Horse Wealth Management LLC now owns 1,217 shares of the healthcare conglomerate’s stock worth $614,000 after purchasing an additional 19 shares in the last quarter. Secure Asset Management LLC lifted its position in shares of UnitedHealth Group by 0.8% during the third quarter. Secure Asset Management LLC now owns 2,456 shares of the healthcare conglomerate’s stock worth $1,238,000 after purchasing an additional 19 shares in the last quarter. Bensler LLC lifted its position in shares of UnitedHealth Group by 0.3% during the third quarter. Bensler LLC now owns 7,293 shares of the healthcare conglomerate’s stock worth $3,677,000 after purchasing an additional 19 shares in the last quarter. Finally, Texas Capital Bancshares Inc TX lifted its position in shares of UnitedHealth Group by 1.1% during the third quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock worth $855,000 after purchasing an additional 19 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of NYSE UNH traded down $4.86 during mid-day trading on Tuesday, hitting $486.37. 3,645,655 shares of the company were exchanged, compared to its average volume of 4,543,351. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. The stock has a 50 day simple moving average of $487.49 and a 200-day simple moving average of $514.76. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70. The firm has a market cap of $448.40 billion, a price-to-earnings ratio of 29.73, a price-to-earnings-growth ratio of 1.38 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. During the same quarter last year, the company earned $6.26 earnings per share. UnitedHealth Group’s quarterly revenue was up 8.6% compared to the same quarter last year. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.55%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is currently 45.97%.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on UNH shares. Deutsche Bank Aktiengesellschaft increased their price target on shares of UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research report on Friday. HSBC upgraded shares of UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 target price on the stock in a research note on Thursday, April 4th. Wells Fargo & Company cut their target price on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research note on Monday, April 8th. Royal Bank of Canada cut their target price on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 17th. Finally, Piper Sandler increased their price target on shares of UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a research note on Wednesday, April 17th. Four research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $570.05.

Insider Activity

In other news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The sale was disclosed in a document filed with the SEC, which is available at this link. In related news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.